Altasciences’ clinical experts have developed an extensive resource library to guide you through all phases of early drug development, from lead candidate selection to clinical proof of concept, and beyond.
Webinars:
 |
Discover the key advantages of conducting clinical trials in North America. |
 |
Explore the flexible selection of pharmacodynamic measures to enhance the pharmacology, safety, and efficacy evaluation of a CNS-active drug in early clinical trials. |
 |
The Path Forward, Altasciences’ Approach to Project Management Learn about our unique approach that can lower your costs and reduce programme timelines by up to 40 percent, from lead candidate selection to clinical proof-of-concept. |
The Altascientist—A Scientific Journal:
 |
End-to-End CNS Drug Development Solutions Explore the complexities of CNS drug development programmes and how partnering with an integrated CRO/CDMO can help you move your molecule seamlessly from one phase to the next. Case studies included! |
 |
The Advantages of Conducting Early Phase Clinical Research in Canada In light of the regulatory constraints in Europe, discover the benefits (including time and cost savings) and ease of conducting early phase research in Canada. |
 |
Shortening Drug Development Timelines With Asian Ethnobridging Trials Learn how an Asian ethnobridging strategy reduces drug development costs, and shortens the NDA timeline when it includes conducting necessary analyses in Asian subjects during Phase I studies. |
 |
Planning your First-in-Human Trial This issue serves as a broad roadmap for successfully conducting first-in-human (FIH) studies. |
eBook:
 |
First-in-Human Solution for Small and Biologics Explore how we simplify the drug development journey for you, and deliver a stress-free experience with a turnkey first-in-human solution. |
We can accelerate the development of your molecules by up to 40%, from lead identification to clinical POC.
 |
 |
